iShares US Pharmaceuticals ETF
IHE
IHE
143 hedge funds and large institutions have $387M invested in iShares US Pharmaceuticals ETF in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 143 → 143 (0)
0.9% less ownership
Funds ownership: 57.71% → 56.82% (-0.9%)
Holders
143
Holding in Top 10
2
Calls
$411K
Puts
–
Top Buyers
| 1 | +$18.9M | |
| 2 | +$12.2M | |
| 3 | +$12.1M | |
| 4 |
RCM
Raleigh Capital Management
Cary,
North Carolina
|
+$1.71M |
| 5 |
W
WorthPointe
La Jolla,
California
|
+$1.18M |
Top Sellers
| 1 | -$7.36M | |
| 2 | -$7.22M | |
| 3 | -$6.29M | |
| 4 |
VCM
Virtue Capital Management
Brentwood,
Tennessee
|
-$4.98M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.39M |